InSphero AG Acquires PhenoVista Biosciences, Inc.
May 20, 2026
InSphero AG announced it has acquired PhenoVista Biosciences, Inc., a San Diego-based contract research organization specializing in high-content imaging and phenotypic assay technologies. The deal is intended to expand InSphero’s advanced 3D, cell-based assay and imaging capabilities and accelerate adoption of more predictive, human-relevant drug discovery and toxicology workflows.
- Buyers
- InSphero AG
- Targets
- PhenoVista Biosciences, Inc.
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.